Business Description
Diva Laboratories Ltd
SIC : 111
ISIN : TW0004153002
Description
Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 97.72 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 412.62 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.99 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.6 | |||||
| 3-Year EBITDA Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | 25.4 | |||||
| 3-Year FCF Growth Rate | 23.9 | |||||
| 3-Year Book Growth Rate | -2.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.86 | |||||
| 9-Day RSI | 37.06 | |||||
| 14-Day RSI | 37.77 | |||||
| 6-1 Month Momentum % | 15.28 | |||||
| 12-1 Month Momentum % | 33.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.54 | |||||
| Quick Ratio | 3.72 | |||||
| Cash Ratio | 2.56 | |||||
| Days Inventory | 155.44 | |||||
| Days Sales Outstanding | 136.59 | |||||
| Days Payable | 60.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.25 | |||||
| Dividend Payout Ratio | 1 | |||||
| 3-Year Dividend Growth Rate | -40.7 | |||||
| Forward Dividend Yield % | 3.25 | |||||
| 5-Year Yield-on-Cost % | 3.25 | |||||
| 3-Year Average Share Buyback Ratio | 0.8 | |||||
| Shareholder Yield % | 2.98 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.3 | |||||
| Operating Margin % | 11.49 | |||||
| Net Margin % | 11.03 | |||||
| FCF Margin % | 12.49 | |||||
| ROE % | 6.96 | |||||
| ROA % | 5.52 | |||||
| ROIC % | 12.31 | |||||
| 3-Year ROIIC % | 7.46 | |||||
| ROC (Joel Greenblatt) % | 20.83 | |||||
| ROCE % | 8.29 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.03 | |||||
| PE Ratio without NRI | 32.27 | |||||
| Shiller PE Ratio | 170.19 | |||||
| Price-to-Owner-Earnings | 30.85 | |||||
| PS Ratio | 3.73 | |||||
| PB Ratio | 2.3 | |||||
| Price-to-Tangible-Book | 2.31 | |||||
| Price-to-Free-Cash-Flow | 29.94 | |||||
| Price-to-Operating-Cash-Flow | 29.64 | |||||
| EV-to-EBIT | 21.76 | |||||
| EV-to-EBITDA | 19.82 | |||||
| EV-to-Revenue | 2.87 | |||||
| EV-to-FCF | 21.51 | |||||
| Price-to-Projected-FCF | 1.78 | |||||
| Price-to-Median-PS-Value | 1.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.15 | |||||
| Price-to-Graham-Number | 1.59 | |||||
| Price-to-Net-Current-Asset-Value | 3.15 | |||||
| Price-to-Net-Cash | 7.22 | |||||
| Earnings Yield (Greenblatt) % | 4.6 | |||||
| FCF Yield % | 3.36 | |||||
| Forward Rate of Return (Yacktman) % | 12.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diva Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 639.056 | ||
| EPS (TTM) (NT$) | 1.19 | ||
| Beta | 0.16 | ||
| Volatility % | 34.23 | ||
| 14-Day RSI | 37.77 | ||
| 14-Day ATR (NT$) | 1.758343 | ||
| 20-Day SMA (NT$) | 43.2725 | ||
| 12-1 Month Momentum % | 33.04 | ||
| 52-Week Range (NT$) | 33.5 - 55.8 | ||
| Shares Outstanding (Mil) | 58.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diva Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diva Laboratories Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Diva Laboratories Ltd Frequently Asked Questions
What is Diva Laboratories Ltd(ROCO:4153)'s stock price today?
The current price of ROCO:4153 is NT$40.50. The 52 week high of ROCO:4153 is NT$55.80 and 52 week low is NT$33.50.
When is next earnings date of Diva Laboratories Ltd(ROCO:4153)?
The next earnings date of Diva Laboratories Ltd(ROCO:4153) is .
Does Diva Laboratories Ltd(ROCO:4153) pay dividends? If so, how much?
The Dividend Yield %  of Diva Laboratories Ltd(ROCO:4153) is 3.25% (As of Today), Highest Dividend Payout Ratio of Diva Laboratories Ltd(ROCO:4153) was 4.83. The lowest was 0.16. And the median was 0.77. The  Forward Dividend Yield % of Diva Laboratories Ltd(ROCO:4153) is 3.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers